Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 146 entries
Sorted by: Best Match Show Resources per page
Review of National Defense Science and Engineering Graduate Fellowship

NSF Scholarships in Science, Technology, Engineering, and Mathematics AND Program Evaluation

Belanich J.
GSID: 3A0VhPZDKAIJ
J Belanich, WA DeMaio, KI Fisher, MA Cummings - 2019 - apps.dtic.mil

This report reviews the National Defense Science and Engineering Graduate NDSEG Fellowship program, which has provided over 3,000 awards to US citizens for the pursuit of graduate degrees in science, engineering, or other fields of study designated as priority...

Cite
Belanich, J., DeMaio, W. A., Fisher, K. I., & Cummings, M. A. (2019). Review of National Defense Science and Engineering Graduate Fellowship.
Belanich, James, et al. "Review of National Defense Science and Engineering Graduate Fellowship." (2019).
Copy Download .nbib Format: MLA
Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis.

Asian Pacific journal of cancer prevention : APJCP

Raeisi Shahraki H, Bemani P, Jalali M.
PMID: 28612601
Asian Pac J Cancer Prev. 2017 May 01;18(5):1453-1457. doi: 10.22034/APJCP.2017.18.5.1453.

Objectives: In order to identify genes with the greatest contribution to bladder cancer, we proposed a sparse model making the best discrimination from other patients. Methods: In a cross-sectional study, 22 genes with a key role in most cancers...

Cite
Raeisi Shahraki H, Bemani P, Jalali M. Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis. Asian Pac J Cancer Prev. 2017;18(5):1453-1457doi: 10.22034/APJCP.2017.18.5.1453.
Raeisi Shahraki, H., Bemani, P., & Jalali, M. (2017). Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis. Asian Pacific journal of cancer prevention : APJCP, 18(5), 1453-1457. https://doi.org/10.22034/APJCP.2017.18.5.1453
Raeisi Shahraki, Hadi, et al. "Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis." Asian Pacific journal of cancer prevention : APJCP vol. 18,5 (2017): 1453-1457. doi: https://doi.org/10.22034/APJCP.2017.18.5.1453
Raeisi Shahraki H, Bemani P, Jalali M. Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis. Asian Pac J Cancer Prev. 2017 May 01;18(5):1453-1457. doi: 10.22034/APJCP.2017.18.5.1453. PMID: 28612601; PMCID: PMC5555561.
Copy Download .nbib Format: NLM
Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management.

Seminars in oncology

Belani C, Lynch T.
PMID: 28140076
Semin Oncol. 2001 Feb;28:10-14.

Docetaxel (Taxotere; Aventis, Antony, France) is among the most effective agents for the treatment of non-small cell lung cancer and its use in combination with cisplatin is a logical development. Docetaxel has been combined with cisplatin and is well-tolerated...

Cite
Belani C, Lynch T. Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management. Semin Oncol. 2001;28:10-14
Belani, C., & Lynch, T. (2001). Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management. Seminars in oncology, 2810-14.
Belani, Chandra, and Lynch, Thomas. "Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management." Seminars in oncology vol. 28 (2001): 10-14.
Belani C, Lynch T. Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management. Semin Oncol. 2001 Feb;28:10-14. PMID: 28140076.
Copy Download .nbib Format: NLM
Recurrent Aeromonas Bacteremia Due to Contaminated Well Water.

Open forum infectious diseases

Katz MJ, Parrish NM, Belani A, Shah M.
PMID: 26495324
Open Forum Infect Dis. 2015 Oct 20;2(4):ofv142. doi: 10.1093/ofid/ofv142. eCollection 2015 Dec.

Although they are ubiquitous to aquatic environments, Aeromonas species have traditionally been considered nonvirulent; however, in the past 30 years, they have emerged as important human pathogens that can cause a wide spectrum of disease. In this study, we...

Cite
Katz MJ, Parrish NM, Belani A, et al. Recurrent Aeromonas Bacteremia Due to Contaminated Well Water. Open Forum Infect Dis. 2015;2(4):ofv142doi: 10.1093/ofid/ofv142.
Katz, M. J., Parrish, N. M., Belani, A., & Shah, M. (2015). Recurrent Aeromonas Bacteremia Due to Contaminated Well Water. Open forum infectious diseases, 2(4), ofv142. https://doi.org/10.1093/ofid/ofv142
Katz, Morgan J, et al. "Recurrent Aeromonas Bacteremia Due to Contaminated Well Water." Open forum infectious diseases vol. 2,4 (2015): ofv142. doi: https://doi.org/10.1093/ofid/ofv142
Katz MJ, Parrish NM, Belani A, Shah M. Recurrent Aeromonas Bacteremia Due to Contaminated Well Water. Open Forum Infect Dis. 2015 Oct 20;2(4):ofv142. doi: 10.1093/ofid/ofv142. eCollection 2015 Dec. PMID: 26495324; PMCID: PMC4612566.
Copy Download .nbib Format: NLM
Targeted immunotherapy for non-small cell lung cancer.

World journal of clinical oncology

Vasekar M, Liu X, Zheng H, Belani CP.
PMID: 24829850
World J Clin Oncol. 2014 May 10;5(2):39-47. doi: 10.5306/wjco.v5.i2.39.

Targeted therapies that deliver the expected anti-tumor effects while mitigating the adverse effects are taking the cancer world by storm. The need for such therapies in non-small cell lung cancer (NSCLC), where systemic cytotoxic chemotherapies still remain the backbone...

Cite
Vasekar M, Liu X, Zheng H, et al. Targeted immunotherapy for non-small cell lung cancer. World J Clin Oncol. 2014;5(2):39-47doi: 10.5306/wjco.v5.i2.39.
Vasekar, M., Liu, X., Zheng, H., & Belani, C. P. (2014). Targeted immunotherapy for non-small cell lung cancer. World journal of clinical oncology, 5(2), 39-47. https://doi.org/10.5306/wjco.v5.i2.39
Vasekar, Monali, et al. "Targeted immunotherapy for non-small cell lung cancer." World journal of clinical oncology vol. 5,2 (2014): 39-47. doi: https://doi.org/10.5306/wjco.v5.i2.39
Vasekar M, Liu X, Zheng H, Belani CP. Targeted immunotherapy for non-small cell lung cancer. World J Clin Oncol. 2014 May 10;5(2):39-47. doi: 10.5306/wjco.v5.i2.39. PMID: 24829850; PMCID: PMC4014795.
Copy Download .nbib Format: NLM
Doublet chemotherapy for advanced non-small cell lung cancer.

Clinical lung cancer

Ramalingam S, Belani CP.
PMID: 14653870
Clin Lung Cancer. 2002 Jul;4(1):13.

No abstract available.

Cite
Ramalingam S, Belani CP. Doublet chemotherapy for advanced non-small cell lung cancer. Clin Lung Cancer. 2002;4(1):13
Ramalingam, S., & Belani, C. P. (2002). Doublet chemotherapy for advanced non-small cell lung cancer. Clinical lung cancer, 4(1), 13.
Ramalingam, Sakkaraiappan, and Belani, Chandra P. "Doublet chemotherapy for advanced non-small cell lung cancer." Clinical lung cancer vol. 4,1 (2002): 13.
Ramalingam S, Belani CP. Doublet chemotherapy for advanced non-small cell lung cancer. Clin Lung Cancer. 2002 Jul;4(1):13. PMID: 14653870.
Copy Download .nbib Format: NLM
Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials.

Clinical lung cancer

Belani CP, Sauder RJ.
PMID: 14720341
Clin Lung Cancer. 2002 May;3:S7-11. doi: 10.3816/clc.2002.s.007.

The role of docetaxel-containing doublets as first-line chemotherapy for patients with advanced and metastatic non-small-cell lung cancer (NSCLC) was evaluated in a large randomized trial. Docetaxel/cisplatin and docetaxel/carboplatin were compared with the reference regimen of vinorelbine/cisplatin. After adjustment for...

Cite
Belani CP, Sauder RJ. Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 2002;3:S7-11doi: 10.3816/clc.2002.s.007.
Belani, C. P., & Sauder, R. J. (2002). Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials. Clinical lung cancer, 3S7-11. https://doi.org/10.3816/clc.2002.s.007
Belani, Chandra P, and Sauder, Ryan J. "Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials." Clinical lung cancer vol. 3 (2002): S7-11. doi: https://doi.org/10.3816/clc.2002.s.007
Belani CP, Sauder RJ. Docetaxel/platinum in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 2002 May;3:S7-11. doi: 10.3816/clc.2002.s.007. PMID: 14720341.
Copy Download .nbib Format: NLM
Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials.

Clinical lung cancer

Belani CP.
PMID: 14720348
Clin Lung Cancer. 2002 Mar;3:S5-9. doi: 10.3816/clc.2002.s.001.

Since the 1980s, cisplatin therapy for advanced non-small-cell lung cancer (NSCLC) has shown improvement in patient outcome with respect to overall survival. In the past decade, several new agents, such as the taxanes (paclitaxel and docetaxel), gemcitabine, vinorelbine, and...

Cite
Belani CP. Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 2002;3:S5-9doi: 10.3816/clc.2002.s.001.
Belani, C. P. (2002). Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clinical lung cancer, 3S5-9. https://doi.org/10.3816/clc.2002.s.001
Belani, Chandra P. "Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials." Clinical lung cancer vol. 3 (2002): S5-9. doi: https://doi.org/10.3816/clc.2002.s.001
Belani CP. Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 2002 Mar;3:S5-9. doi: 10.3816/clc.2002.s.001. PMID: 14720348.
Copy Download .nbib Format: NLM
Docetaxel in combination with platinum compounds for non small-cell lung cancer.

Clinical lung cancer

Belani CP.
PMID: 14725736
Clin Lung Cancer. 2000 Apr;1:S10-4. doi: 10.3816/clc.2000.s.002.

Assessing the combination of docetaxel with cisplatin or carboplatin was based on their activity as single agents, their nonoverlapping toxicity profiles, and their lack of cross-resistance. Phase I studies of docetaxel in combination with cisplatin established that 75 mg/m2...

Cite
Belani CP. Docetaxel in combination with platinum compounds for non small-cell lung cancer. Clin Lung Cancer. 2000;1:S10-4doi: 10.3816/clc.2000.s.002.
Belani, C. P. (2000). Docetaxel in combination with platinum compounds for non small-cell lung cancer. Clinical lung cancer, 1S10-4. https://doi.org/10.3816/clc.2000.s.002
Belani, C P. "Docetaxel in combination with platinum compounds for non small-cell lung cancer." Clinical lung cancer vol. 1 (2000): S10-4. doi: https://doi.org/10.3816/clc.2000.s.002
Belani CP. Docetaxel in combination with platinum compounds for non small-cell lung cancer. Clin Lung Cancer. 2000 Apr;1:S10-4. doi: 10.3816/clc.2000.s.002. PMID: 14725736.
Copy Download .nbib Format: NLM
Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study.

Irish journal of psychological medicine

Kingston T, Collier S, Hevey D, McCormick MM, Besani C, Cooney J, O'Dwyer AM.
PMID: 30185265
Ir J Psychol Med. 2015 Sep;32(3):265-274. doi: 10.1017/ipm.2014.81.

OBJECTIVES: Mindfulness-based cognitive therapy (MBCT) is a group-based intervention similar to mindfulness-based stress reduction, but which includes cognitive therapy techniques. This study investigates its usefulness in the treatment of depressive, anxiety and stress/distress symptoms in cancer patients referred to...

Cite
Kingston T, Collier S, Hevey D, et al. Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study. Ir J Psychol Med. 2015;32(3):265-274doi: 10.1017/ipm.2014.81.
Kingston, T., Collier, S., Hevey, D., McCormick, M. M., Besani, C., Cooney, J., & O'Dwyer, A. M. (2015). Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study. Irish journal of psychological medicine, 32(3), 265-274. https://doi.org/10.1017/ipm.2014.81
Kingston, T, et al. "Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study." Irish journal of psychological medicine vol. 32,3 (2015): 265-274. doi: https://doi.org/10.1017/ipm.2014.81
Kingston T, Collier S, Hevey D, McCormick MM, Besani C, Cooney J, O'Dwyer AM. Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study. Ir J Psychol Med. 2015 Sep;32(3):265-274. doi: 10.1017/ipm.2014.81. PMID: 30185265.
Copy Download .nbib Format: NLM
South African HIV self-testing policy and guidance considerations.

Southern African journal of HIV medicine

Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A.
PMID: 29568643
South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017.

The gap in HIV testing remains significant and new modalities such as HIV self-testing (HIVST) have been recommended to reach key and under-tested populations. In December 2016, the World Health Organization (WHO) released the Guidelines on HIV Self-Testing and...

Cite
Venter F, Majam M, Jankelowitz L, et al. South African HIV self-testing policy and guidance considerations. South Afr J HIV Med. 2017;18(1):775doi: 10.4102/sajhivmed.v18i1.775.
Venter, F., Majam, M., Jankelowitz, L., Adams, S., Moorhouse, M., Carmona, S., Stevens, W., Msimanga, B. R., Allen, D., Balani, P., Nevhutalu, Z., Rhagnath, N., Shroufi, A., Devillé, W., Kazangarare, V., van der Wiel, R., Templeman, H., Puren, A., Tucker, T., van Cutsem, G., Conradie, F., Dong, K., Chidarikire, T., & Gray, A. (2017). South African HIV self-testing policy and guidance considerations. Southern African journal of HIV medicine, 18(1), 775. https://doi.org/10.4102/sajhivmed.v18i1.775
Venter, Francois, et al. "South African HIV self-testing policy and guidance considerations." Southern African journal of HIV medicine vol. 18,1 (2017): 775. doi: https://doi.org/10.4102/sajhivmed.v18i1.775
Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A. South African HIV self-testing policy and guidance considerations. South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017. PMID: 29568643; PMCID: PMC5842980.
Copy Download .nbib Format: NLM
Role of ketamine for analgesia in adults and children.

Journal of anaesthesiology, clinical pharmacology

Vadivelu N, Schermer E, Kodumudi V, Belani K, Urman RD, Kaye AD.
PMID: 27625475
J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):298-306. doi: 10.4103/0970-9185.168149.

Ketamine an N-methyl-D-aspartate (NMDA) receptor blocking agent and a dissociative anesthetic with neurostimulatory side effects. In recent years, multiple research trials as well as systematic reviews and meta-analyses suggest the usefulness of ketamine as a strong analgesic used in...

Cite
Vadivelu N, Schermer E, Kodumudi V, et al. Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016;32(3):298-306doi: 10.4103/0970-9185.168149.
Vadivelu, N., Schermer, E., Kodumudi, V., Belani, K., Urman, R. D., & Kaye, A. D. (2016). Role of ketamine for analgesia in adults and children. Journal of anaesthesiology, clinical pharmacology, 32(3), 298-306. https://doi.org/10.4103/0970-9185.168149
Vadivelu, Nalini, et al. "Role of ketamine for analgesia in adults and children." Journal of anaesthesiology, clinical pharmacology vol. 32,3 (2016): 298-306. doi: https://doi.org/10.4103/0970-9185.168149
Vadivelu N, Schermer E, Kodumudi V, Belani K, Urman RD, Kaye AD. Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):298-306. doi: 10.4103/0970-9185.168149. PMID: 27625475; PMCID: PMC5009833.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 146 entries